263 related articles for article (PubMed ID: 31462328)
1. Prevalence and aggressiveness of papillary thyroid carcinoma in surgically-treated graves' disease patients: a retrospective matched cohort study.
You E; Mascarella MA; Al Jassim A; Forest VI; Hier MP; Tamilia M; Pusztaszeri M; Payne RJ
J Otolaryngol Head Neck Surg; 2019 Aug; 48(1):40. PubMed ID: 31462328
[TBL] [Abstract][Full Text] [Related]
2. Higher incidence of tall cell variant of papillary thyroid carcinoma in Graves' Disease.
Boutzios G; Vasileiadis I; Zapanti E; Charitoudis G; Karakostas E; Ieromonachou P; Karatzas T
Thyroid; 2014 Feb; 24(2):347-54. PubMed ID: 23786233
[TBL] [Abstract][Full Text] [Related]
3. Thyroid carcinoma in patients with Graves' disease: an institutional experience.
Wei S; Baloch ZW; LiVolsi VA
Endocr Pathol; 2015 Mar; 26(1):48-53. PubMed ID: 25332114
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of papillary thyroid cancer in patients with Graves' disease: a propensity score-matched analysis.
Kwon H; Moon BI
World J Surg Oncol; 2020 Oct; 18(1):266. PubMed ID: 33050937
[TBL] [Abstract][Full Text] [Related]
5. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
[TBL] [Abstract][Full Text] [Related]
6. Incidentally Discovered Papillary Thyroid Microcarcinomas Are More Frequently Found in Patients with Chronic Lymphocytic Thyroiditis Than with Multinodular Goiter or Graves' Disease.
Paparodis RD; Karvounis E; Bantouna D; Chourpiliadis C; Chourpiliadi H; Livadas S; Imam S; Jaume JC
Thyroid; 2020 Apr; 30(4):531-535. PubMed ID: 31950881
[No Abstract] [Full Text] [Related]
7. Graves' disease and papillary thyroid carcinoma: case report and literature review of a single academic center.
Arosemena MA; Cipriani NA; Dumitrescu AM
BMC Endocr Disord; 2022 Aug; 22(1):199. PubMed ID: 35945543
[TBL] [Abstract][Full Text] [Related]
8. Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study.
Premoli P; Tanda ML; Piantanida E; Veronesi G; Gallo D; Masiello E; Rosetti S; Cusini C; Boi F; Bulla J; Rodia R; Mariotti S; Capelli V; Rotondi M; Magri F; Chiovato L; Rocchi R; Campopiano MC; Elisei R; Vitti P; Barbato F; Pilli T; Castagna MG; Pacini F; Bartalena L
J Endocrinol Invest; 2020 Jan; 43(1):109-116. PubMed ID: 31327128
[TBL] [Abstract][Full Text] [Related]
9. Coexistent thyroid nodules in patients with graves' disease: What is the frequency and the risk of malignancy?
Shi HH; McHenry CR
Am J Surg; 2018 Nov; 216(5):980-984. PubMed ID: 30049435
[TBL] [Abstract][Full Text] [Related]
10. Recent outcome of Graves' disease patients with papillary thyroid cancer.
Yano Y; Shibuya H; Kitagawa W; Nagahama M; Sugino K; Ito K; Ito K
Eur J Endocrinol; 2007 Sep; 157(3):325-9. PubMed ID: 17766715
[TBL] [Abstract][Full Text] [Related]
11. Increased mortality in patients with differentiated thyroid cancer associated with Graves' disease.
Pellegriti G; Mannarino C; Russo M; Terranova R; Marturano I; Vigneri R; Belfiore A
J Clin Endocrinol Metab; 2013 Mar; 98(3):1014-21. PubMed ID: 23348395
[TBL] [Abstract][Full Text] [Related]
12. Incidental papillary thyroid carcinoma: clinical characteristics and prognostic factors among patients with Graves' disease and euthyroid goiter, Cleveland Clinic experience.
Ergin AB; Saralaya S; Olansky L
Am J Otolaryngol; 2014; 35(6):784-90. PubMed ID: 25128909
[TBL] [Abstract][Full Text] [Related]
13. Total thyroidectomy is the preferred treatment for patients with Graves' disease and a thyroid nodule.
Boostrom S; Richards ML
Otolaryngol Head Neck Surg; 2007 Feb; 136(2):278-81. PubMed ID: 17275554
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors of thyroid cancer in patients with Graves' disease.
Ren M; Wu MC; Shang CZ; Wang XY; Zhang JL; Cheng H; Xu MT; Yan L
World J Surg; 2014 Jan; 38(1):80-7. PubMed ID: 24166025
[TBL] [Abstract][Full Text] [Related]
15. Predictive Impact of Metastatic Lymph Node Burden on Distant Metastasis Across Papillary Thyroid Cancer Variants.
Ho AS; Luu M; Shafqat I; Mallen-St Clair J; Chen MM; Chen Y; Jain M; Ali N; Patio C; Filarski CF; Lin DC; Bankston H; Braunstein GD; Sacks WL; Zumsteg ZS
Thyroid; 2021 Oct; 31(10):1549-1557. PubMed ID: 34470466
[No Abstract] [Full Text] [Related]
16. Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer.
Hales IB; McElduff A; Crummer P; Clifton-Bligh P; Delbridge L; Hoschl R; Poole A; Reeve TS; Wilmshurst E; Wiseman J
J Clin Endocrinol Metab; 1992 Sep; 75(3):886-9. PubMed ID: 1517381
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
[TBL] [Abstract][Full Text] [Related]
18. Thyroid nodules in Graves' disease: implications in an endemically iodine deficient area.
Mishra A; Mishra SK
J Postgrad Med; 2001; 47(4):244-7. PubMed ID: 11832639
[TBL] [Abstract][Full Text] [Related]
19. Association of patient age with high-risk pathologic features in papillary thyroid cancer.
Niemann AC; Reid AT; Smith J; Hammond J; DeBolle SA; Wei I; Soong-Ho Lee C; Hughes DT
J Surg Res; 2017 May; 211():228-232. PubMed ID: 28501122
[TBL] [Abstract][Full Text] [Related]
20. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
